Form 4: Halliburton COO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Halliburton's EVP and COO, Jeffrey Shannon Slocum, sold 5,441 shares of common stock for $33.82 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Jeffrey Shannon Slocum, Halliburton's Director, EVP, and COO, reported a sale of common stock.
- The transaction involved the disposition of 5,441 shares of Halliburton Common Stock.
- The shares were sold at a price of $33.82 per share.
- The sale was executed on March 16, 2026.
- This transaction was conducted pursuant to a Rule 10b5-1 trading plan adopted by Mr. Slocum on August 7, 2025.
- Following the sale, Mr. Slocum beneficially owns 187,422.952 shares of Common Stock directly.
- Mr. Slocum also holds derivative securities, including options to buy 12,090 shares at an exercise price of $49.61 (exercisable from January 2, 2018, and expiring January 2, 2028) and 3,722 shares at an exercise price of $55.68 (exercisable from January 3, 2017, and expiring January 3, 2027).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, typical for executive compensation and personal financial planning, especially given the pre-arranged 10b5-1 plan.
Positives
- The sale was conducted under a Rule 10b5-1 trading plan, indicating a pre-arranged, non-discretionary transaction, which is generally viewed as a standard practice for executive financial planning.
- The reporting person retains a substantial beneficial ownership of 187,422.952 shares of common stock, in addition to derivative securities.
Negatives
- Insider selling, even if pre-planned, reduces the direct equity stake of a key executive in the company.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, as it primarily reports an insider transaction.
Industry Context
StockSavvy.ai notes that insider transactions, particularly those under Rule 10b5-1 plans, are common in the oilfield services sector as executives manage their equity compensation and personal financial planning. These pre-arranged sales are generally viewed as less indicative of management's immediate sentiment about the company's prospects compared to open market, discretionary sales.
Comparison to Industry Standards
- Form 4 filings are standard regulatory disclosures for insider transactions across all industries.
- The use of a 10b5-1 plan by Halliburton's COO aligns with best practices for executive stock sales, similar to those observed at peers like Schlumberger (SLB) or Baker Hughes (BKR), which aim to mitigate concerns about trading on material non-public information.
Stakeholder Impact
- Shareholders: The sale slightly reduces the direct ownership stake of a key executive, but the pre-planned nature mitigates concerns about negative sentiment regarding the company's future.
- Employees: No direct impact.
- Customers/Suppliers/Creditors: No direct impact.
Key Dates
| Date | Description |
|---|---|
| 01/03/2017 | Date exercisable for 3,722 options to buy common stock. |
| 01/02/2018 | Date exercisable for 12,090 options to buy common stock. |
| 01/03/2027 | Expiration date for 3,722 options to buy common stock. |
| 01/02/2028 | Expiration date for 12,090 options to buy common stock. |
| 08/07/2025 | Date Rule 10b5-1 trading plan was adopted by the reporting person. |
| 03/16/2026 | Date of the reported transaction (sale of common stock). |
| 03/17/2026 | Signature date of the reporting person. |
Recommendation
holdThe filing reports a routine, pre-planned insider stock sale by a Halliburton executive under a 10b5-1 plan. Such transactions are common for executive compensation and personal financial management and typically do not signal a change in the company's fundamental outlook. Therefore, it does not warrant a change in investment recommendation based solely on this disclosure.
Keywords
Halliburton, HAL, SEC Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Jeffrey Shannon Slocum, Common Stock, Executive Compensation, Director, COO, Oilfield Services
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.